Park J, Yoo YS, Shin K, et al. - Researchers conducted this prospective, randomized controlled study to examine the impacts of preoperative Lipiflow (Johnson & Johnson, USA) treatment prior to cataract surgery on meibomian gland dysfunction (MGD) and dry eye induced by surgery. Participants in the study were 124 patients (124 eyes) with planned surgery for senile cataract. Based on the administration of Lipiflow treatment three weeks prior to cataract surgery, participants were randomly assigned to one of two groups: control or Lipiflow. Preoperative Lipiflow treatment prior to cataract surgery may be a safe and effective intervention for alleviating MGD and dry eye caused by surgery. It may be recommended not only for patients with preoperative MGD, but also for those who do not have baseline MGD, to prevent the development of MGD and dry eye caused by ocular surgery.